Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Medical Journal of Cairo University [The]. 2007; 75 (3): 609-617
in English | IMEMR | ID: emr-145706

ABSTRACT

This experimental study aimed to investigate the possible effect of resveratrol [RSV], an antioxidant agent, during Gentamicin [GEN] treatment as a prophylactic modality against drug induced renal tubular affection. The study comprised 30 normal rats divided into 3 equal groups: Control group: Did not receive medications, GEN Group: Received IP injection of GEN [80mg/kg/day for 6 days] and RSV+GEN Group: Received IP injection of GEN [80mg/kg/day] and RSV [10mg/ kg/day for 6 days]. At the 6th day, blood samples were withdrawn for estimation of serum creatinine, urea and Na and K ions, then all animals were sacrificed and both kidneys were immediately removed and a renal cortex biopsy was obtained for estimation of renal tissue extract activity of glutathione [GSH], glutathione-S-transferase [GST], superoxide dismutase [SOD] and catalase [CAT] and tissue content of non-protein sulphydryl [NPSH] and lipid peroxides. Both kidneys were dissected out for histological studies and scored for seventy of tubular changes. In comparison to control group; GEN caused a significant elevation [p[1]<0.001] of serum urea and creatinifte associated with increased serum Na+ and decreased K+ levels with significantly increased levels of SOD, MDA and NPSH levels and decreased levels of GSH, GST and CAT in renal tissue extract. On contrary, RSV injection in combination with GEN significantly ameliorated the effects imposed by GEN on the oxidant/antioxidant equilibrium manifested as a non-significant increase of tissue extract levels of MDA and NPSH associated with non-significant decrease of tissue extract level of GSH and GST in GEN+RS V group compared to control group [p[1]>0.05] but tissue extract levels of SOD and CAT were significantly increased [p[1]=0.016 and 0.005, respectively] compared to control group. RSV lessened the nephrotoxic effect of Gentamicin in combination group with a significant decrease of serum urea and creatinine levels compared to that estimated in GEN group, [p[2]=0.008] with a significantly decreased serum Na+ and increased serum K+ compared to levels estimated in GEN group [p[2]=0.007 and =0.008, respectively]. Light microscopic examination of renal tissue obtained from rats injected with GEN for 6 days, showed degenerative changes with necrosis of proximal tubular cells and contracted glomeuli associated with tubular and glomerular vacuolation. There was tissue edema and intense inflammatory cellular infiltrates. Semi-quantitative analysis of tubular necrosis, tubular vacuolization and parietal cell hyperplasia in animals treated by GEN and GEN+RSV showed a significant reduction of scores of each parameter in GEN+RSV group compared to GEN group with no necrosis reported in 55.6% and no parietal cell hyperplasia in 33.3% of animals included in GEN+RSV group, while all GEN treated animals showed tubular necrosis and vacuolation with parietal cell hyperplasia of varied scores. It could be concluded that concomitant administration of resveratrol during Gentamicin therapy in high dose and for long period could ameliorate the structural changes and preserve the oxidant/antioxidant balance in renal tissue with minimization of affection of renal function tests


Subject(s)
Animals, Laboratory , Kidney/pathology , Histology , Rats , Stilbenes , Treatment Outcome , Antioxidants/blood , Kidney Function Tests
SELECTION OF CITATIONS
SEARCH DETAIL